1
/
of
0
FDA ANDA 213118 Review Report for Carboprost Tromethamine Injection
FDA ANDA 213118 Review Report for Carboprost Tromethamine Injection
Regular price
$69.00 USD
Regular price
Sale price
$69.00 USD
Unit price
/
per
Original Request: 1. The US FDA reviewing report (including ANDA reviewing report and PAS reviewing report) for ANDA 213118 (MAH:Sunny Pharmtech Inc.) Carboprost Tromethamine Injection, USP 250 mcg/mL, including the Summary Review, Chemistry Review, Pharmacology Review, etc.
Tags: Pharma, ANDA, 2024
Tags: Pharma, ANDA, 2024
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details